Company intelligence / Profile preview

Epigene Labs

Paris, Île-de-France, Francelinkedin.com ↗

Ownership: Private
Employees: ~33
Development stage: Preclinical

Overview

Epigene Labs provides a data-driven AI and bioinformatics platform (mCUBE) that aggregates and harmonizes multi-dimensional genomic data from over 100,000 patient samples across more than 30 cancer types. The company enables identification of novel oncology drug targets and biomarkers to accelerate precision medicine R&D. No direct clinical results reported; the focus is on supporting discovery for partners in pharma/biotech.

Therapeutic areas: Oncology
Modalities: ImmunotherapiesAntigen-targeting modalities
Industry: Drug Discovery Services

Partnerships

Servier (multi-year collaboration on AI for precision oncology R&D)AstraZeneca (support/partnership indicated)

Beyond the preview

Go deeper on Epigene Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epigene Labs.

Explore the full profile